Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124517853 | 12451785 | 3 | F | 201603 | 20160802 | 20160609 | 20160808 | EXP | PHHY2016DE079327 | NOVARTIS | 0.00 | A | F | Y | 0.00000 | 20160808 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124517853 | 12451785 | 1 | PS | TASIGNA | NILOTINIB | 1 | Oral | 600 MG, QD (PER DAY) | Y | 22068 | 600 | MG | CAPSULE | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124517853 | 12451785 | 1 | Chronic myeloid leukaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124517853 | 12451785 | OT |
| 124517853 | 12451785 | HO |
| 124517853 | 12451785 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124517853 | 12451785 | Activated partial thromboplastin time prolonged | |
| 124517853 | 12451785 | Activated partial thromboplastin time shortened | |
| 124517853 | 12451785 | Acute myocardial infarction | |
| 124517853 | 12451785 | Angina pectoris | |
| 124517853 | 12451785 | Aspiration | |
| 124517853 | 12451785 | Atelectasis | |
| 124517853 | 12451785 | Atrioventricular block complete | |
| 124517853 | 12451785 | Blood glucose increased | |
| 124517853 | 12451785 | Blood lactate dehydrogenase increased | |
| 124517853 | 12451785 | Coma scale | |
| 124517853 | 12451785 | Coronary artery disease | |
| 124517853 | 12451785 | Cyanosis | |
| 124517853 | 12451785 | Gamma-glutamyltransferase increased | |
| 124517853 | 12451785 | Glomerular filtration rate decreased | |
| 124517853 | 12451785 | Nasopharyngitis | |
| 124517853 | 12451785 | Nausea | |
| 124517853 | 12451785 | Posture abnormal | |
| 124517853 | 12451785 | Syncope | |
| 124517853 | 12451785 | Unresponsive to stimuli |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124517853 | 12451785 | 1 | 201204 | 201603 | 0 |